Tuesday, March 28, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
Yale School of Nursing
Oncology Nurse Practitioner
Smilow Cancer Center at Yale New Haven
Yale Comprehensive Cancer Center
New Haven, Connecticut
Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)
This activity is intended for nurses and nurse practitioners involved in the care of patients with NSCLC.
The goal of this activity is that learners will be better able to understand the role of immunotherapy (IO) in the treatment of metastatic NSCLC and provide strategies for optimizing the care of these patients.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
Yale School of Nursing
Oncology Nurse Practitioner
Smilow Cancer Center at Yale New Haven
Yale Comprehensive Cancer Center
New Haven, Connecticut
Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CE Released: 6/2/2022
Valid for credit through: 6/2/2023
processing....
The goal of this activity is that learners will be better able to understand the role of immunotherapy (IO) in the treatment of metastatic NSCLC and provide strategies for optimizing the care of these patients.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
